CA Stock MarketDetailed Quotes
DTC Defence Therapeutics Inc
- 0.550
- +0.030+5.77%
15min DelayMarket Closed Sep 27 15:49 ET
25.05MMarket Cap-1833P/E (TTM)
0.580High0.500Low29.00KVolume0.520Open0.520Pre Close15.70KTurnover3.01052wk High0.07%Turnover Ratio45.54MShares0.48052wk Low-0.3EPS TTM23.67MFloat Cap8.150Historical HighLossP/E (Static)43.03MShs Float0.480Historical Low-0.3EPS LYR15.39%Amplitude--Dividend TTM-6.96P/B1Lot Size--Div YieldTTM
Defence Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.00%-4.29M | 75.23%-532.17K | 48.00%-940.92K | 35.76%-1.39M | 7.09%-1.42M | -26.69%-7.66M | -69.05%-2.15M | -16.88%-1.81M | -25.96%-2.17M | -1.79%-1.53M |
| Net income from continuing operations | -95.08%-13.19M | 22.01%-1.35M | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 7.91%-6.76M | 20.64%-1.73M | 20.74%-1.34M | -2.42%-1.99M | -11.30%-1.7M |
| Depreciation and amortization | 557.77%90.92K | 6,064.39%48.64K | 7,813.33%22.55K | -45.50%6.95K | --12.79K | --13.82K | --789 | --285 | --12.75K | --0 |
| Remuneration paid in stock | 1,877.34%5.84M | --0 | --0 | 2,461.54%5.84M | --0 | -20.50%295.18K | --0 | --63.18K | -8.31%227.86K | -88.12%4.14K |
| Deferred tax | --0 | ---- | ---- | ---- | ---- | ---105K | ---- | ---- | ---- | ---- |
| Other non cashItems | 51.31%397.85K | 43.94%148.96K | -12.50%94.86K | --58.08K | --95.96K | --262.93K | --103.49K | --108.41K | ---- | ---- |
| Change In working capital | 289.43%2.58M | 247.54%618.46K | 142.22%269.43K | 316.67%1.02M | 295.55%666.75K | -246.67%-1.36M | -151.16%-419.18K | -535.27%-638.08K | -1,497.94%-472.88K | 2,193.16%168.56K |
| -Change in receivables | 143.56%53.08K | 41.31%-35.93K | 183.59%12.41K | 64.26%-12.47K | 917.17%89.07K | -377.76%-121.85K | -982.44%-61.22K | -2,943.87%-14.85K | -145.66%-34.88K | 60.21%-10.9K |
| -Change in prepaid assets | 222.13%431.09K | 100.72%2.9K | 56.09%42.82K | 32.00%-21.31K | 653.02%406.69K | -251.21%-352.98K | -1,445.82%-403.07K | -76.76%27.43K | 57.07%-31.35K | 130.78%54.01K |
| -Change in payables and accrued expense | 336.26%2.1M | 1,344.10%651.49K | 132.92%214.2K | 360.27%1.06M | 36.30%170.99K | -190.03%-886.75K | -94.33%45.11K | -2,419.35%-650.67K | -1,132.98%-406.65K | -35.60%125.46K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.00%-4.29M | 75.23%-532.17K | 48.00%-940.92K | 35.76%-1.39M | 7.09%-1.42M | -26.69%-7.66M | -69.05%-2.15M | -16.88%-1.81M | -25.96%-2.17M | -1.79%-1.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -208.86%-203.24K | 436.62%16.94K | -213.68K | 0 | -6.5K | -65.8K | -5.03K | 0 | -60.77K | 0 |
| Net PPE purchase and sale | -208.86%-203.24K | 436.62%16.94K | ---213.68K | --0 | ---6.5K | ---65.8K | ---5.03K | --0 | ---60.77K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -208.86%-203.24K | 436.62%16.94K | ---213.68K | --0 | ---6.5K | ---65.8K | ---5.03K | --0 | ---60.77K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -82.46%1.76M | -97.23%57.24K | -70.87%1.32M | -82.56%394.52K | -101.27%-14.66K | 811.46%10.01M | 997.12%2.07M | 1,460.81%4.52M | 3,683.22%2.26M | 106.15%1.15M |
| Net issuance payments of debt | -98.86%26.73K | 576.34%42.24K | 554.43%28.38K | ---- | ---- | --2.36M | --6.25K | ---6.25K | ---- | ---- |
| Net common stock issuance | -77.10%1.89M | -99.31%15K | -69.46%1.45M | 305.89%423.75K | --0 | 651.12%8.25M | 1,058.33%2.18M | 1,538.55%4.75M | 74.64%104.4K | 116.07%1.21M |
| Cash dividends paid | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
| Interest paid (cash flow from financing activities) | -478.61%-36.14K | --0 | ---- | ---- | ---14.66K | ---6.25K | ---6.25K | ---- | ---- | --0 |
| Net other financing activities | 78.81%-124.61K | --0 | ---- | ---- | ---- | ---587.94K | ---115.43K | ---219.13K | ---197.79K | ---55.59K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -82.46%1.76M | -97.23%57.24K | -70.87%1.32M | -82.56%394.52K | -101.27%-14.66K | 811.46%10.01M | 997.12%2.07M | 1,460.81%4.52M | 3,683.22%2.26M | 106.15%1.15M |
| Net cash flow | ||||||||||
| Beginning cash position | 451.20%2.79M | -82.12%514.53K | 116.09%351K | 931.90%1.35M | 451.20%2.79M | -90.71%506.7K | 81.09%2.88M | -94.30%162.43K | -97.10%130.84K | -90.71%506.7K |
| Current changes in cash | -219.69%-2.74M | -440.28%-457.98K | -93.98%163.53K | -3,262.45%-999.11K | -283.87%-1.44M | 146.22%2.29M | 92.17%-84.77K | 315.82%2.72M | 101.90%31.59K | 60.15%-375.86K |
| End cash Position | -97.98%56.55K | -97.98%56.55K | -82.12%514.53K | 116.09%351K | 931.90%1.35M | 451.20%2.79M | 451.20%2.79M | 81.09%2.88M | -94.30%162.43K | -97.10%130.84K |
| Free cash from | 41.84%-4.49M | 76.08%-515.23K | 36.19%-1.15M | 37.51%-1.39M | 6.66%-1.43M | -27.78%-7.72M | -69.45%-2.15M | -16.88%-1.81M | -29.49%-2.23M | -1.79%-1.53M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data